The mean in situ numbers of CD3+ CD4 or CD8 TILs in MSS tumor centers tended to be lower than in MSI-H tumors (Supplementary Figure S1E), which may explain the higher APC to TIL ratio in MSS tumor suspensions from the second cohort. This evidence concerns the gene CD8A and neoplasm.